Silent corticogonadotroph adenomas: Clinical and cellular characteristics and long-term outcomes

Hormones and Cancer

Volumn 1, Issue 2, 2010, Pages 80-92

  Cooper, Odelia ^a   Ben Shlomo, Anat ^a   Bonert, Vivien ^a   Bannykh, Serguei ^a   Mirocha, James ^a   Melmed, Shlomo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Corticotroph adenoma; Gonadotroph adenoma; Nonfunctioning adenoma; Pituitary adenoma

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; NEUROGENIC DIFFERENTIATION FACTOR; NUCLEAR RECEPTOR DAX 1; THYROTROPIN;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SIZE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; ELECTRON MICROSCOPY; FEMALE; GONADOTROPH ADENOMA; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; HYPOPITUITARISM; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SILENT CORTICOGONADOTROPH ADENOMA;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADULT; AGED; FEMALE; GONADOTROPINS; HUMANS; MALE; MIDDLE AGED; RECURRENCE;

EID: 78650186578     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-010-0014-x     Document Type: Article

References (61)

1. Melmed S (2003) Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112:1603-1618.
2. The Committee of Brain Tumor Registry of Japan (1992) Brain Tumor Registry of Japan. Neurol Med Chir (Tokyo) 32:381-547.
3. Nieman LK, Beverly MKB, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93:1526-1540.
4. Meier CA, Biller BM (1997) Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am 26:741-762.
5. Sahli R, Christ ER, Seiler R, Kappeler A, Vajtai I (2006) Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review. Pathol Res Pract 202:457-464.
6. Cho HY, Cho SW, Kim SW, Shin CS, Park KS, Kim SY (2009) Silent corticotroph adenomas have unique recurrence characteristics as compared with other non-functioning pituitary adenomas. Clin Endocrinol (Oxf) (in press).
7. Lopez JA, Kleinschmidt-Demasters BK, S Chun-I Woodmansee WW, Lillehei KO (2004) Silent corticotroph adenomas: further clinical and pathological observations. Hum Pathol 35:1137-1147.
8. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, Laws ER Jr, Young WF Jr (2000) Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 47:723-729, discussion 729-30.
9. Baldeweg SE, Pollock JR, Powell M, Ahlquist J (2005) A spectrum of behaviour in silent corticotroph pituitary adenomas. Br J Neurosurg 19:38-42.
10. Webb KM, Laurent JJ, Okonkwo DO, Beatriz Lopes M, Vance ML, Laws ER Jr (2003) Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery 53:1076-1084 discussion 1084-5.
11. Bradley KJ, Wass JA, Turner HE (2003) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol (Oxf) 58:59-64.
12. Psaras T, Honegger J, Buslei R, Saeger W, Klein D, Capper D, Meyermann R, Mittelbronn M (2007) Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence. Exp Clin Endocrinol Diabetes 115:610-615.
13. Yokoyama S, Kawahara Y, Sano T, Nakayama M, Kitajima S-I, Kuratsu J-I (2001) A case of non-functioning pituitary adenoma with Cushing's syndrome upon recurrence. Neuropathology 21:288-293.
14. Pawlikowski M, Kunert-Radek J, Radek M (2008) "Silent"corticotropinoma. Neuro Endocrinol Lett 29:347-350.
15. Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K, Sano T (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61:580-584 discussion 584-5.
16. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, Yapicier O, Young WF Jr, Meyer FB, Kuroki T, Riehle DL, Laws ER Jr (2006) Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59:341-353 discussion 341-53.
17. namegr typeauthornamesnameDelellis/sname/namex/xnamex /xfnameRA/fname/namexx, /xnamesnameLloyd/snamex /xfnameRV/fname/namex, /xnamesnameHeitz/snamex /xfnamePU/fname/namex, /xnamesnameEng/snamex /xfnameC/fname/name/namegr (2004) Pathology and genetics of tumors of endocrine organs.
18. Kojima Y, Suzuki S, Yamamura K, Ohhashi G, Yamamoto I (2002) Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay. Endocr J 49:285-292.
19. Horvath E, Kovacs K, Lloyd RV (1999) Pars intermedia of the human pituitary revisited: morphologic aspects and frequency of hyperplasia of POMC-peptide immunoreactive cells. Endocr Pathol 10:55-64.
20. Ohta S, Nishizawa S, Oki Y, Yokoyama T, Namba H (2002) Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype Iimmunohistochemical study. Pituitary 5:221-223.
21. Wu W, Rosenfeld MG (2006) In Endocrinology, D. L. J and J. J. Larry, 291-308. Elsevier Saunders, Philadelphia.
22. Burrows HL, Douglas KR, Seasholtz AF, Camper SA (1999) Genealogy of the anterior pituitary gland: tracing a family tree. Trends Endocrinol Metab 10:343-352.
23. Liu J, Lin C, Gleiberman A, Ohgi KA, Herman T, Huang H-P, Tsai M-J, Rosenfeld MG (2001) Tbx19, a tissue-selective regulator of POMC gene expression. Proc Natl Acad Sci U SA 98:8674-8679.
24. Lamolet B, Pulichino A-M, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J (2001) A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104:849-859.
25. Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino A-M, Dufour H, Grisoli F, Enjalbert A, Drouin J, Brue T (2003) Differential regulation of proopiomelanocortin and pituitaryrestricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab 88:3050-3056.
26. Poulin G, Turgeon B, Drouin J (1997) NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol 17:6673-6682.
27. Lavoie P-L, Budry L, Balsalobre A, Drouin J (2008) Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin. Mol Endocrinol 22:1647-1657.
28. Oyama K, Sanno N, Teramoto A, Yoshiyuki Osamura R (2001) Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Mod Pathol 14:892-899.
29. Asa SL, Bamberger A-M, Cao B, Wong M, Parker KL, Ezzat S (1996) The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 81:2165-2170.
30. Kawabe K, Shikayama T, Tsuboi H, Oka S, Oba K, Yanase T, Nawata H, Morohashi K-I (1999) Dax-1 as one of the target genes of Ad4BP/SF-1. Mol Endocrinol 13:1267-1284.
31. Ikuyama S, Mu Y-M, Ohe K, Nakagaki H, Fukushima T, Takayanagi R, Nawata H (1998) Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas. Clin Endocrinol (Oxf) 48:647-654.
32. Kageyama K, Ikeda H, Nigawara T, Sakihara S, Suda T (2007) Expression of adrenocorticotropic hormone, prolactin and transcriptional factors in clinically nonfunctioning pituitary adenoma. Endocr J 54:961-968.
33. Tateno T, Izumiyama H, Doi M, Yoshimoto T, Shichiri M, Inoshita N, Oyama K, Yamada S, Hirata Y (2007) Differential gene expression in ACTH-secreting and non-functioning pituitary tumors. Eur J Endocrinol 157:717-724.
34. Suzuki M, Egashira N, Kajiya H, Minematsu T, Takekoshi S, Tahara S, Sanno N, Teramoto A, Osamura RY (2008) ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells. Endocr Pathol 19(1):17-26.
35. Bates AS, Farrell WE, Bicknell JE, Mcnicol A-M, Talbot AJ, Broome JC, Perrett CW, Thakker RV, Clayton RN (1997) Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab 82:818-824.
36. Vidal S, Syro L, Horvath E, Uribe H, Kovacs K (1999) Ultrastructural and immunoelectron microscopic study of three unusual plurihormonal pituitary adenomas. Ultrastruct Pathol 23:141-148.
37. Ngai HK, Chan KW, Or SB, Yau WL (1985) A rapid method for reprocessing paraffin sections for diagnostic electron microscopy. J Pathol 145:59-62.
38. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W (1980) Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 98:617-638.
39. Sakaguchi H, Koshiyama H, Sano T, Inoue D, Hashimoto N, Aoki N, Nakao K (1997) A case of nonfunctioning pituitary adenoma resembling so-called silent corticotroph adenoma. Endocr J 44:329-333.
40. Drouin J, Bilodeau S, Vallette S (2007) Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency. Clin Genet 72:175-182.
41. Asa SL (1998) Tumors of the pituitary gland. In Atlas of Tumor Pathology, Series 3, Fascicle 22. Washington, DC: Armed Forces Institute of Pathology.
42. Sano T, Kovacs K, Asa SL, Yamada S, Sanno N, Yokoyama S, Takami H (2002) Pituitary adenoma with "honeycomb Golgi" appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical Cushing disease. Endocr Pathol 13:125-130.
43. Kim K, Yamada S, Usui M, Sano T (2005) Co-localization of honeycomb golgi and ACTH granules in a giant ACTH-producing pituitary adenoma. Endocr Pathol 16:239-244.
44. Ikeda H, Yoshimoto T, Ogawa Y, Mizoi K, Murakami O (1997) Clinico-pathological study of Cushing's disease with large pituitary adenoma. Clin Endocrinol (Oxf) 46:669-679.
45. Sano T, Mader R, Asa SL, Qian ZR, Hino A, Yamada S (2003) "Honeycomb Golgi" in pituitary adenomas: not a marker of gonadotroph adenomas. Endocr Pathol 14:363-368.
46. Aylwin SJ, Welch JP, Davey CL, Geddes JF, Wood DF, Besser GM, Grossman AB, Monson JP, Burrin JM (2001) The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas. J Clin Endocrinol Metab 86:2476-2483.
47. Pulichino A-M, Vallette-Kasic S, Tsai JP-Y, Couture C, Gauthier Y, Drouin J (2003) Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 17:738-747.
48. Sano T, Kovacs K, Asa SL, Smyth HS (1990) Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases. Virchows Arch A Pathol Anat Histopathol 417:361-367.
49. Sano T, Yamada S (1994) Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: special reference to gonadotropin-positive adenomas. Pathol Int 44:697-703.
50. Skelly RH, Korbonits M, Grossman A, Besser GM, Monson JP, Geddes JF, Burrin JM (2000) Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion. J Clin Endocrinol Metab 85:2537-2542.
51. Desai B, Burrin JM, Nott CA, Geddes JF, Lamb EJ, Aylwin SJB, Wood DF, Thakkar C, Monson JP (1995) Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours-an in vitro and immunohistochemical study. Eur J Endocrinol 133:25-32.
52. Berg KK, Scheithauer BW, Felix I, Kovacs K, Horvath E, Klee GG, Laws ER Jr (1990) Pituitary adenomas that produce adrenocorticotropic hormone and alpha-subunit: clinicopathological, immunohistochemical, ultrastructural, and immunoelectron microscopic studies in nine cases. Neurosurgery 26:397-403.
53. Heshmati HM, Turpin G, Kujas M, Lam X, Van Effenterre R, Racadot J, De Gennes JL (1988) The immunocytochemical heterogeneity of silent pituitary adenomas. Acta Endocrinol (Copenh) 118:533-537.
54. Jautzke G (1988) Simultaneous production of the alpha-subunit of glycoprotein hormones and other hormones in pituitary adenomas. Pathol Res Pract 183:601-605.
55. Landolt AM, Heitz PU, Zenklusen H-R (1988) Production of the alpha-subunit of glycoprotein hormones by pituitary adenomas. Pathol Res Pract 183:610-612.
56. Egensperger R, Scheithauer BW, Horvath E, Kovacs K, Giannini C, Young WF, Lloyd R, Atkinson J, Nippoldt T (2001) Cushing's disease due to plurihormonal adrenocorticotropic hormone and gonadotropin-producing pituitary adenoma. Acta Neuropathol 102:398-403.
57. Kamijo K, Sato M, Saito T, Yachi A, Minase T, Noro H, Kawahara T (1991) An ACTH and FSH producing invasive pituitary adenoma with Crooke's hyalinization. Pathol Res Pract 187:637-641.
58. Osamura RY, Watanabe K (1988) Immunohistochemical studies of human FSH producing pituitary adenomas. Virchows Arch A Pathol Anat Histopathol 413:61-68.
59. Lloyd RV, Fields K, Jin L, Horvath E, Kovacs K (1990) Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization. Am J Pathol 137:479-488.
60. Felix I, Asa SL, Kovacs K, Horvath E (1991) Changes in hormone production of a recurrent silent corticotroph adenoma of the pituitary: a histologic, immunohistochemical, ultrastructural, and tissue culture study. Hum Pathol 22:719-721.
61. Black PM, Hsu DW, Klibanski A, Kliman B, Larry Jameson J, Chester Ridgway E, Hedley-Whyte ET, Zervas NT (1987) Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg 66:244-250.